We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

15 Years HCS: Next Gen Screening Devices Learn from Each Other. Literally. Fast Workflow Development & BigData Image Analytics Used to be a Challenge. What’s Next?

Video   Jun 09, 2015

 



After 15 years our community has created numerous high content screening platforms for many different aspects. Anything from simple 2D cell based to time-lapse 5D in vivo screens is possible. Dealing with large amounts of data still challenges many of the existing platforms. Reducing development times and maintenance cost is now easier than ever if we integrate existing technologies from other disciplines. A HowTo for the rest of us.

 
 
 
 

Recommended Videos

The Advantages of Machine Learning and Artificial Intelligence in the Drug Discovery Process

Video

Dr Ola Engkvist, AstraZeneca, explains how the drug discovery process benefits from artificial intelligence and machine learning.

WATCH NOW

How Deep Learning Architectures Have Improved Chemical Reaction Prediction

Video

Dr Ola Engkvist, AstraZeneca, explains how deep learning architectures improve chemical reaction prediction.

WATCH NOW

Applying Deep Learning Architectures to de novo Molecular Drug Design

Video

Dr Ola Engkvist, AstraZeneca, outlines how deep learning architectures are being applied to drug discovery.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE